Table 1 Selection criteria
Inclusion criteria | Exclusion criteria |
|---|---|
 • English language only  • Human research subjects with a hematological malignancy (>50% of study sample)  • Adult patients (≥18 years of age)  • Primary research  • Peer reviewed articles  • Studies from January 2004 to November 2014  • Prognostic studies (cohort or case-control)  • Median survival of ≤ 3 months, (or >50% sample had died in ICU, or in hospital or within 3 months)  • Reported ‘bedside prognostic factors’ | • Editorials and letters • Discussions / expert opinion papers • Non - peer reviewed • Reports of clinical trials evaluating the effects of a specific treatment (chemotherapy, radiation therapy, etc.) • Systematic reviews of original research (predictive/prognostic cohort studies) |